Preoperative Gadoxetic Acid-Enhanced MRI and Simultaneous Treatment of Early Hepatocellular Carcinoma Prolonged Recurrence-Free Survival of Progressed Hepatocellular Carcinoma Patients after Hepatic Resection

Table 4

Multivariate analysis of prognostic factors for overall and recurrence-free survival after hepatic resection for HCC.

Variable	HR	95% CI	𝑃 value
Overall survival
Esophageal varix (present)	1.49	0.65–3.38	0.34
Platelets (≦10 × 10^4/𝜇L)	4.41	2.04–9.52	<0.01
Child-Pugh classification (B)	1.48	0.53–4.13	0.45
Des-𝛾-carboxy prothrombin (>40 mAU/mL)	3.55	1.72–7.34	<0.01
Liver cirrhosis (present)	1.92	0.89–4.15	0.1
Recurrence-free survival
EOB-MRI (present)	0.56	0.36–0.86	<0.01
Albumin (≦3.5 g/dL)	1.68	0.87–3.26	0.12
Platelets (≦10 × 10^4/𝜇L)	1.66	0.99–2.79	0.054
Child-Pugh classification (B)	1.52	0.61–3.79	0.36
Hepatitis C antibody (positive)	1.33	0.94–2.34	0.09
Number of advanced HCCs (multiple)	2.1	1.29–3.40	<0.01